Format
Sort by
Items per page

Send to

Choose Destination

Best matches for finasteride:

[Finasteride adverse effects: An update]. Carreño-Orellana N et al. Rev Med Chil. (2016)

Persistent Sexual Dysfunction with Finasteride 1 mg Taken for Hair Loss. Guo M et al. Pharmacotherapy. (2016)

Atypical post-finasteride syndrome: A pharmacological riddle. Gupta AK et al. Indian J Pharmacol. (2016)

Search results

Items: 1 to 20 of 3148

1.

A phytosterol-enriched saw palmetto supercritical CO2 extract ameliorates testosterone-induced benign prostatic hyperplasia by regulating the inflammatory and apoptotic proteins in a rat model.

Sudeep HV, Venkatakrishna K, Amrutharaj B, Anitha, Shyamprasad K.

BMC Complement Altern Med. 2019 Oct 17;19(1):270. doi: 10.1186/s12906-019-2697-z.

2.

Hair Transplantation.

Zito PM, Raggio BS.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Oct 3.

3.

Frontal fibrosing alopecia in Asians: a retrospective clinical study.

Suchonwanit P, Pakornphadungsit K, Leerunyakul K, Khunkhet S, Sriphojanart T, Rojhirunsakool S.

Int J Dermatol. 2019 Oct 11. doi: 10.1111/ijd.14672. [Epub ahead of print]

PMID:
31605393
4.

Receipt of 5-Alpha Reductase Inhibitors Before Radical Cystectomy: Do They Render High-Grade Bladder Tumors Less Aggressive?

McMartin C, Lacombe L, Fradet V, Fradet Y, Lodde M, Toren P.

Clin Genitourin Cancer. 2019 Aug 5. pii: S1558-7673(19)30244-7. doi: 10.1016/j.clgc.2019.07.016. [Epub ahead of print]

PMID:
31594737
5.

Effect of Paecilomyces tenuipes Extract on Testosterone-Induced Benign Prostatic Hyperplasia in Sprague-Dawley Rats.

Choi YJ, Kim EK, Fan M, Tang Y, Hwang YJ, Sung SH.

Int J Environ Res Public Health. 2019 Oct 7;16(19). pii: E3764. doi: 10.3390/ijerph16193764.

6.

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.

Franco JV, Turk T, Jung JH, Xiao YT, Iakhno S, Tirapegui FI, Garrote V, Vietto V.

Cochrane Database Syst Rev. 2019 Oct 6;10:CD012552. doi: 10.1002/14651858.CD012552.pub2. [Epub ahead of print] Review.

PMID:
31587256
7.

Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.

Cicero AFG, Allkanjari O, Busetto GM, Cai T, Larganà G, Magri V, Perletti G, Robustelli Della Cuna FS, Russo GI, Stamatiou K, Trinchieri A, Vitalone A.

Arch Ital Urol Androl. 2019 Oct 2;91(3). doi: 10.4081/aiua.2019.3.139.

8.

Post-Finasteride Syndrome: An Induced Delusional Disorder with the Potential of a Mass Psychogenic Illness?

Trüeb RM, Régnier A, Dutra Rezende H, Gavazzoni Dias MFR.

Skin Appendage Disord. 2019 Aug;5(5):320-326. doi: 10.1159/000497362. Epub 2019 Mar 22.

PMID:
31559258
9.

Influence of Postoperative Finasteride Therapy on Recurrence of Gynecomastia After Mastectomy in Men Taking Finasteride for Alopecia.

Lee SG, Park PJ, Lee SR, Koo BH, Byun GY, Kim MJ, Kang HJ, Kim S, Oh BS, Lee YH.

Am J Mens Health. 2019 Sep-Oct;13(5):1557988319871423. doi: 10.1177/1557988319871423.

10.

6'-Sialyllactose Ameliorates In Vivo and In Vitro Benign Prostatic Hyperplasia by Regulating the E2F1/pRb-AR Pathway.

Jin BR, Kim HJ, Kim EY, Chung TW, Ha KT, An HJ.

Nutrients. 2019 Sep 12;11(9). pii: E2203. doi: 10.3390/nu11092203.

11.

Oral medications for central serous chorioretinopathy: a literature review.

Fusi-Rubiano W, Saedon H, Patel V, Yang YC.

Eye (Lond). 2019 Sep 16. doi: 10.1038/s41433-019-0568-y. [Epub ahead of print]

PMID:
31527760
12.

Which chemicals should be grouped together for mixture risk assessments of male reproductive disorders?

Kortenkamp A.

Mol Cell Endocrinol. 2019 Sep 13;499:110581. doi: 10.1016/j.mce.2019.110581. [Epub ahead of print] Review.

PMID:
31525431
13.

Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety.

Chen H, Zhang J, Hu P, Qian Y, Li J, Shen J.

Bioorg Med Chem. 2019 Oct 15;27(20):115081. doi: 10.1016/j.bmc.2019.115081. Epub 2019 Aug 28.

PMID:
31493989
14.

Nonsurgical hair restoration treatment.

Nazarian RS, Farberg AS, Hashim PW, Goldenberg G.

Cutis. 2019 Jul;104(1):17-24.

PMID:
31487342
15.
16.

Low-dose in utero exposure to finasteride promotes developmental changes in both male and female gerbil prostates.

Maldarine JS, Sanches BDA, Santos VA, Amaro GM, Calmon MF, Rahal P, Góes RM, Vilamaior PSL, Taboga SR.

Environ Toxicol. 2019 Aug 27. doi: 10.1002/tox.22838. [Epub ahead of print]

PMID:
31454150
17.

A Systematic Review of Outcomes and Patient Satisfaction Following Surgical and Non-surgical Treatments for Hair Loss.

Rosati P, Barone M, Alessandri Bonetti M, Giorgino R, Panasiti V, Coppola R, Tambone V, Persichetti P.

Aesthetic Plast Surg. 2019 Aug 26. doi: 10.1007/s00266-019-01480-9. [Epub ahead of print] Review.

PMID:
31451851
18.

Pediatric Androgenetic Alopecia: a Review.

Griggs J, Burroway B, Tosti A.

J Am Acad Dermatol. 2019 Aug 12. pii: S0190-9622(19)32565-4. doi: 10.1016/j.jaad.2019.08.018. [Epub ahead of print] Review.

PMID:
31415838
19.

Physiopathology and current treatments of androgenetic alopecia: Going beyond androgens and anti-androgens.

Katzer T, Leite Junior A, Beck R, da Silva C.

Dermatol Ther. 2019 Sep;32(5):e13059. doi: 10.1111/dth.13059. Epub 2019 Aug 26. Review.

PMID:
31400254
20.

Post-finasteride syndrome.

Gray SL, Semla TP.

BMJ. 2019 Aug 9;366:l5047. doi: 10.1136/bmj.l5047. No abstract available.

PMID:
31399423

Supplemental Content

Loading ...
Support Center